| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2045298 | F | Growth inhibition of Botryodiplodia theobromae at 150 mg/mL after 48 hrs by mycelium growth rate method | Lasiodiplodia theobromae | 39 | organism-based format | Scientific Literature | ||
| 2. | ALA2045299 | F | Growth inhibition of Fusarium oxysporum f. sp. niveum at 150 mg/mL after 48 hrs by mycelium growth rate method | Fusarium oxysporum f. sp. niveum | 39 | assay format | Scientific Literature | ||
| 3. | ALA2045300 | F | Growth inhibition of Fusarium oxysporum f. sp. cubense at 150 mg/mL after 48 hrs by mycelium growth rate method | Fusarium oxysporum f. sp. cubense | 38 | assay format | Scientific Literature | ||
| 4. | ALA2045301 | F | Growth inhibition of Colletotrichum musae at 150 mg/mL after 48 hrs by mycelium growth rate method | Colletotrichum musae | 39 | organism-based format | Scientific Literature | ||
| 5. | ALA2045302 | F | Growth inhibition of Phyricularia oryzae Cav. at 150 mg/mL after 48 hrs by mycelium growth rate method | Pyricularia grisea | 39 | organism-based format | Scientific Literature | ||
| 6. | ALA2045303 | F | Growth inhibition of Colletotrichum gloeosporioides at 150 mg/mL after 48 hrs by mycelium growth rate method | Colletotrichum gloeosporioides | 38 | organism-based format | Scientific Literature | ||
| 7. | ALA2045304 | F | Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay | Homo sapiens | 39 | cell-based format | Scientific Literature | ||
| 8. | ALA2045305 | F | Cytotoxicity against human A549 cells after 48 hrs by MTT assay | Homo sapiens | 39 | cell-based format | Scientific Literature | ||
| 9. | ALA2045306 | F | Cytotoxicity against human PC3M cells after 48 hrs by MTT assay | Homo sapiens | 39 | cell-based format | Scientific Literature | ||
| 10. | ALA2045307 | F | Cytotoxicity against human MKN45 cells after 48 hrs by MTT assay | Homo sapiens | 39 | cell-based format | Scientific Literature | ||
| 11. | ALA2045308 | F | Ratio of Fluorouracil IC50 to compound IC50 for human A549 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 12. | ALA2045309 | F | Ratio of Fluorouracil IC50 to compound IC50 for human HepG2 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 13. | ALA2045310 | F | Cell cycle arrest in human HepG2 cells assessed as Sub-G0 phase cells at 4 uM after 24 hrs by flow cytometry (Rvb = 2.48%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 14. | ALA2045311 | F | Cell cycle arrest in human HepG2 cells assessed as G0/G1 phase cells at 4 uM after 24 hrs by flow cytometry (Rvb = 54.65%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 15. | ALA2045312 | F | Cell cycle arrest in human HepG2 cells assessed as S phase cells at 4 uM after 24 hrs by flow cytometry (Rvb = 29.84%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA2045313 | F | Cell cycle arrest in human HepG2 cells assessed as G2/M phase cells at 4 uM after 24 hrs by flow cytometry (Rvb = 16.38%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 17. | ALA2045314 | F | Cell cycle arrest in human HepG2 cells assessed as Sub-G0 phase cells at 8 uM after 24 hrs by flow cytometry (Rvb = 2.48%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 18. | ALA2045315 | F | Cell cycle arrest in human HepG2 cells assessed as G0/G1 phase cells at 8 uM after 24 hrs by flow cytometry (Rvb = 54.65%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 19. | ALA2045316 | F | Cell cycle arrest in human HepG2 cells assessed as S phase cells at 8 uM after 24 hrs by flow cytometry (Rvb = 29.84%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 20. | ALA2045317 | F | Cell cycle arrest in human HepG2 cells assessed as G2/M phase cells at 8 uM after 24 hrs by flow cytometry (Rvb = 16.38%) | Homo sapiens | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!